Neurava
PrivateLast Round
Grant
Apr 23, 2026
Total Funding Raised
$6.96M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Neurava operates in Healthcare & Life Sciences and is based in Baltimore, Maryland. Its latest recorded funding round was a Grant round in April 2026.
Neurava is a medical technology company that develops wearable diagnostic devices to monitor and alert for seizures and cardiorespiratory dysfunctions in patients with epilepsy to mitigate the risk of SUDEP.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Health IoT, Sensors
Business Model
B2B2C
Customer Profile
Hardware + Subscription, Subscription SaaS, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurava Comparables
Compare Neurava with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| monikit | 85% | |
| Epilert | 81% | |
| Smart Monitor | 81% |
For institutional investors. Book with your work email.
Neurava Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 23, 2026 | ||||
| Seed | Apr 3, 2024 | ||||
| Seed | Nov 1, 2021 | ||||
| Grant | Apr 9, 2021 | ||||
| Pre Seed | Dec 19, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Neurava Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Biomedical Imaging and Bioengineering | Grant |
| Purdue Research Foundation | Seed |
| Elevate Ventures | Seed, Pre Seed |
| iO Life Ventures | Seed |
| UCB Ventures | Seed |
| SWPDC | Grant |
| National Institute of Neurological Disorders and Stroke (NINDS) | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors grew 76% MoM, reaching 2.7K.
- Apr 26, 2026
Grew 60% QoQ from 5 to 8 employees.
For institutional investors. Book with your work email.
Neurava Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Neurava's valuation, stock price, and market status.
Is Neurava a public or private company?
Neurava is a private company.
What is the current stock price of Neurava?
Neurava is a private company, so its shares have no public market price. Caplight tracks Neurava's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Neurava worth (valuation)?
Valuation information for Neurava is not publicly available.
Can I buy Neurava stock?
Neurava shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Neurava's last funding round?
Neurava's most recent funding round was Grant on April 23, 2026.
Who are the main investors in Neurava?
Key investors in Neurava include Elevate Ventures, Life Science Angels.
Will Neurava IPO soon?
No public IPO plans have been announced for Neurava.
How can I track Neurava secondary market activity?
Caplight tracks bids, offers, and trades in Neurava's shares on secondary markets.